EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Vulval Lichen Sclerosus Associated With Immune Checkpoint Inhibitor Therapy: A Case Series of 11 Patients

Sophie Walter iD, Francesca Watts, Raquel Ruiz Araujo iD, Thevaki Wain, Amanda Glanz iD, Diona Damian iD, Matteo S Carlino iD, Alexander M Menzies iD, Georgina V Long iD, Linda K Martin iD

Australasian Journal of Dermatology · 2026

DOI: 10.1111/ajd.70058 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Australasian Journal of Dermatology, 2026. Verfasst von Sophie Walter und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Vulvar Lichen Sclerosus, Melanoma, Skin Neoplasms. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There have only been a limited number of case reports that have described vulval lichen sclerosus in patients receiving immune checkpoint inhibitor (ICI) therapy. We describe 11 cases of vulval lichen sclerosus in patients with melanoma treated with ICIs, and in nine of these cases, the lichen sclerosus symptoms began after ICI commencement. This represents the largest reported series to date and highlights the need for clinician awareness of this potential immune‐related adverse effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsVulvar Lichen SclerosusMelanomaSkin NeoplasmsHumansFemaleAgedMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

adverse effectdermatologygenitalimmune checkpoint inhibitorlichen sclerosusmelanomavulval

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Department of Diagnostic Oncology and Tissue Pathology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Westmead Hospital, Sydney, Australia.
  • Dermatology Department, Royal Prince Alfred Hospital, Sydney, Australia.
  • Sydney Melanoma Diagnostic Centre, Sydney, Australia.

ORCID-Profile: Sophie Walter, Raquel Ruiz Araujo, Amanda Glanz, Diona Damian, Matteo S Carlino, Alexander M Menzies, Georgina V Long, Linda K Martin

Zitieren

APA

Walter, S., Watts, F., Ruiz Araujo, R., Wain, T., Glanz, A., Damian, D., Carlino, M. S., Menzies, A. M., Long, G. V., & Martin, L. K. (2026). Vulval Lichen Sclerosus Associated With Immune Checkpoint Inhibitor Therapy: A Case Series of 11 Patients. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70058

Vancouver

Walter S, Watts F, Ruiz Araujo R, Wain T, Glanz A, Damian D, et al. Vulval Lichen Sclerosus Associated With Immune Checkpoint Inhibitor Therapy: A Case Series of 11 Patients. Australasian Journal of Dermatology. 2026. doi:10.1111/ajd.70058

BibTeX
@article{Walter2026,
  author = {Walter, Sophie and Watts, Francesca and Ruiz Araujo, Raquel and Wain, Thevaki and Glanz, Amanda and Damian, Diona and Carlino, Matteo S and Menzies, Alexander M and Long, Georgina V and Martin, Linda K},
  title = {Vulval Lichen Sclerosus Associated With Immune Checkpoint Inhibitor Therapy: A Case Series of 11 Patients},
  journal = {Australasian Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ajd.70058}
}
Kostenlos starten →